DIPG Clinical Trials

Recruiting Trials - Current as of: 2019-11-18

34 clinical trials are currently available across 6 different countries:

Clinical Trial
Sponsor
Country
United States of America
United States of AmericaNational Cancer Institute (NCI)

Volitinib in Treating Participants With Recurrent or Refractory Primary CNS Tumors
Last Updated: 2019-11-07
Originally Posted: 2018-07-24

United States of America
United States of AmericaNational Institutes of Health Clinical Center (CC)
United States of America
United States of AmericaUniversity of California, San Francisco
United States of America
United States of AmericaAugusta University
United States of America
United States of AmericaUniversity of California, San Francisco
United States of America
United States of AmericaUniversity of California, San Francisco

Fimepinostat in Treating Brain Tumors in Children and Young Adults
Last Updated: 2019-10-07
Originally Posted: 2019-03-26

United States of America
United States of AmericaUniversity of Colorado, Denver

Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma
Last Updated: 2019-09-25
Originally Posted: 2016-11-29

United States of America
United States of AmericaPediatric Brain Tumor Consortium

Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma
Last Updated: 2019-09-23
Originally Posted: 2016-02-22

United States of America
United States of AmericaPediatric Brain Tumor Consortium
United States of America
United States of AmericaPediatric Brain Tumor Consortium

Phase I Study of APX005M in Pediatric CNS Tumors
Last Updated: 2019-09-23
Originally Posted: 2017-12-15

United States of America
United States of AmericaOncoceutics, Inc.

ONC201 in Pediatric H3 K27M Gliomas
Last Updated: 2019-09-17
Originally Posted: 2018-01-23

United States of America
United States of AmericaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
United States of America
United States of AmericaEmory University

Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors
Last Updated: 2019-09-03
Originally Posted: 2015-12-15

United States of America
United States of AmericaChildren's Hospital Medical Center, Cincinnati
United States of America
United States of AmericaUniversity of California, San Francisco
Spain
SpainClinica Universidad de Navarra, Universidad de Navarra

Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas
Last Updated: 2019-08-06
Originally Posted: 2017-06-03

United States of America
United States of AmericaSt. Jude Children's Research Hospital
Canada
CanadaUniversity of Calgary

Re-Irradiation of Progressive or Recurrent DIPG
Last Updated: 2019-04-22
Originally Posted: 2017-04-19

United States of America
United States of AmericaChildren's Research Institute
United States of America
United States of AmericaNorthwell Health

A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Last Updated: 2019-03-22
Originally Posted: 2013-04-16

United States of America
United States of AmericaWeill Medical College of Cornell University
Germany
GermanyUniversity of Göttingen

International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)
Last Updated: 2018-08-07
Originally Posted: 2017-08-04

Italy
ItalyFondazione IRCCS Istituto Nazionale dei Tumori, Milano

Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses
Last Updated: 2018-08-02
Originally Posted: 2018-05-14

France
FranceGustave Roussy, Cancer Campus, Grand Paris

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Last Updated: 2018-07-20
Originally Posted: 2014-08-29

Italy
ItalyMeyer Children's Hospital
United States of America
United States of AmericaChildren's Hospital Medical Center, Cincinnati

International Diffuse Intrinsic Pontine Glioma (DIPG) Registry and Repository
Last Updated: 2017-03-30
Originally Posted: 2017-03-08


* indicates the trial status in ongoing and not necessarily recruiting. See trial link for details.